Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type B
- 1 March 1985
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 88 (3), 780-786
- https://doi.org/10.1016/0016-5085(85)90151-9
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Adenine arabinoside 5′-monophosphate treatment of chronic type B hepatitisHepatology, 1982
- Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).Gut, 1982
- Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.Gut, 1982
- NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERS: Survey of 100 Patients from Great BritainThe Lancet, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled studyGastroenterology, 1981